Last reviewed · How we verify
NCT07093996
Endoscopic Pancreatic Duct Stent Placement Versus Conventional Approach in the Treatment of Early Phase Acute Pancreatitis
NA trial testing Endoscopic pancreatic duct stent placement in Acute Pancreatitis (AP) in 200 participants. Not yet recruiting.
1 December 2026
Quick facts
| Lead sponsor | Almazov National Medical Research Centre |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 200 |
| Start date | 1 September 2025 |
| Primary completion | 1 December 2026 |
| Estimated completion | 1 February 2027 |
| Sites | 7 locations across China, Russia |
Drugs / interventions tested
- Endoscopic pancreatic duct stent placement
- Conventional treatment of acute pancreatitis in early phase — full drug profile →
Conditions studied
- Acute Pancreatitis (AP) — all drugs for Acute Pancreatitis (AP) →
Sponsor
Almazov National Medical Research Centre — full company profile →
Who can join
18 and older, any sex, with Acute Pancreatitis (AP). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The planned multicenter randomized study is aimed to assess the efficacy and safety of endoscopic pancreatic duct stenting in adult patients with acute pancreatitis. It is planned to include patients with early-stage nonbiliary pancreatitis in the study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07093996
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Acute Pancreatitis (AP)
Currently open trials in the same condition.
- NCT07439757 — AI-Powered Precision Decision-Making for Pancreatic Diseases · recruiting
- NCT06867120 — Bowel Sound in Predicting the Severity of Acute Pancreatitis: Protocol of a Prospective, Multi-center Study · recruiting
- NCT06835023 — Dextran 40 Plus Ringer's Lactate Vs. Ringer's Lactate Alone for Fluid Resuscitation in Acute Pancreatitis · NA · recruiting
- NCT07450898 — Retrospective Analysis of Acute Pancreatitis After Percutaneous Mechanical Thrombectomy In Treatment Of Thrombotic Disor · recruiting
Other Almazov National Medical Research Centre trials
Trials by the same sponsor.
- NCT07350447 — Predictors of Laparoscopy Conversion in Adhesive Small Bowel Obstruction · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07093996 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Almazov National Medical Research Centre
- Last refreshed: 30 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07093996.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing